UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032751
Receipt number R000037304
Scientific Title Prospective unblinded randomized controlled trial of the effectiveness and safety of 30 W output and 50 W output in the cavotricuspid isthmus linear ablation for common atrial flutter
Date of disclosure of the study information 2018/10/01
Last modified on 2021/10/08 07:04:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective unblinded randomized controlled trial of the effectiveness and safety of 30 W output and 50 W output in the cavotricuspid isthmus linear ablation for common atrial flutter

Acronym

compcarison of 30W output and 50W output inthe cavotricuspid isthmus linear ablation for common atrial flutter

Scientific Title

Prospective unblinded randomized controlled trial of the effectiveness and safety of 30 W output and 50 W output in the cavotricuspid isthmus linear ablation for common atrial flutter

Scientific Title:Acronym

compcarison of 30W output and 50W output inthe cavotricuspid isthmus linear ablation for common atrial flutter

Region

Japan


Condition

Condition

common atrial flutter

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In the treatment of catheter ablation of cavotricuspid isthmus, we compare 30 W and 50 W output for the time to make the lesion, total procedure time, safety and effectiveness.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total ablation time to make complete cavotricuspid isthmus blockline, total procedure time, incidence of complications

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Interventions: ablation at 50 W 10 - 12 seconds

Interventions/Control_2

Control: ablation at 30 W 30 seconds

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Catheter ablation case for atrial fibrillation, atrial flutter

Key exclusion criteria

Recurrence case after ablation of tricuspid vena cavitalis previously performed

History of congenital heart disease, heart surgery and cardiac tamponade

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kaoru
Middle name
Last name Okishige

Organization

Yokohama City Minato Red Cross Hospital

Division name

Cardiology

Zip code

231-8682

Address

3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa Prefecture 231-8682

TEL

045-628-6100

Email

tatsuhiko1984@gmail.com


Public contact

Name of contact person

1st name Tatsuhiko
Middle name
Last name Hirao

Organization

Yokohama City Minato Red Cross Hospital

Division name

Cardiology

Zip code

231-8682

Address

3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa Prefecture 231-8682

TEL

045-628-6100

Homepage URL


Email

tatsuhiko1984@gmail.com


Sponsor or person

Institute

Yokohama City Minato Red Cross Hospital

Institute

Department

Personal name



Funding Source

Organization

Yokohama City Minato Red Cross Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City Minato Red Cross Hospital

Address

3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa Prefecture 231-8682

Tel

045-628-6100

Email

s-furuta.ji@yokohama.jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 05 Month 15 Day

Date of IRB

2018 Year 06 Month 01 Day

Anticipated trial start date

2018 Year 07 Month 01 Day

Last follow-up date

2019 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 05 Month 29 Day

Last modified on

2021 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037304


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name